Venture Leaders Biotech 2022: 10 innovative startups will advance their global growth in Boston – Healiva is among the 10 startups chosen 27 July 2022
New data on Helsinn’s oncology pipeline presented at American Society of Clinical Oncology (ASCO) Annual Meeting 2022 7 June 2022
Healiva® acquisisce da Smith+Nephew due asset di terapia cellulare per la guarigione delle ferite 2 June 2022
Helsinn Establishes New R&D Hub in the U.S. to Support its Global Fully Integrated Targeted Therapy (FITT) Strategy 30 May 2022
Knight Therapeutics and Helsinn Healthcare SA Enter into Exclusive License, Distribution, and Supply Agreement for Akynzeo® and Aloxi® 17 May 2022
United States Ambassador Scott Miller meets the Chairman of Farma Industria Ticino Association 12 May 2022
Linkedin